 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | ScTIL / Chineo Medical Technology
New P1 trial, Metastases: A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid Tumors (clinicaltrials.gov) - Aug 12, 2022
P1, N=48, Not yet recruiting, Sponsor: Chinese Academy of Medical Sciences
- | ScTIL / Chineo Medical Technology
New P2a trial: Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies (clinicaltrials.gov) - Apr 21, 2022
P2a, N=30, Not yet recruiting, Sponsor: Peking Union Medical College Hospital